Finance entity

329 Services

Company

Every one of those 1 sits in a single category, markets. 329 Services is most often covered alongside Alto Neuroscience, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 3 original sources each against 2.4 for the same window.

Last mentioned: Mar 24, 2026

Entity pulse

Recent coverage · 329 Services

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about 329 Services

Every one of those 1 sits in a single category, markets. 329 Services is most often covered alongside Alto Neuroscience, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 3 original sources each against 2.4 for the same window. Their average consequence score of 6 runs below the beat's 6.2 for that window. We currently track 1 Finance story that mention 329 Services, all published on March 24, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 119 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering 329 Services. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning 329 Services 1

Markets Bullish

Alto Neuroscience Secures $120M in Private Placement to Advance CNS Pipeline

Alto Neuroscience has successfully raised $120 million through a private placement, a significant capital injection aimed at accelerating its precision psychiatry platform. Led by CFO Nick Smith, the financing highlights growing investor confidence in biomarker-driven approaches to treating central nervous system (CNS) disorders.

3 sources

329 Services is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.